Australian court rules on Baxter fine
Thursday, 26 August 2010
Faaez Samadi
The Federal Court of Australia today fined pharmaceuticals company Baxter Healthcare A$4.9 million (€3.4 million) for anti-competitive practices in the sale of medical supplies.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top